Company Information
CIN
Status
Date of Incorporation
13 June 2006
State / ROC
Bangalore / ROC Bangalore
Last Balance Sheet
31 March 2023
Last Annual Meeting
29 September 2023
Paid Up Capital
1,140,973,600
Authorised Capital
1,250,000,000
Directors
Mohammed Gawir Baig
Manager/Secretary
over 2 years ago
over 2 years ago
K Ravindra Chandrappa .
Director/Designated Partner
over 2 years ago
over 2 years ago
Satish Chander Subbanna
Director/Designated Partner
over 4 years ago
over 4 years ago
Ganesh Sambasivam .
Director/Designated Partner
over 19 years ago
over 19 years ago
Ajay Bhardwaj
Director/Designated Partner
over 19 years ago
over 19 years ago
Patents
The present disclosure is in relation to a compound of Formula I
Formula I
wherein ‘R’ is an acid, ‘n’ is an integer of 1-3, and its derivative, tautomeric form, stereoisomer, polymorph, solvate, polymorphs or intermediates thereof. The disclosure also relates to method of preparation of said compounds, and their...
The present disclosure relates to polymorphic form of PQQ and/or its salts represented by formula I
Formula I
wherein “n” and “m” are selected from a group consisting of: (a) “n” = 3, “m” = 0 and (b) “n” = 1, “m” = 2; and; R3 is Na+.
The present disclosure also relates to a process for preparing the polymor...
The present disclosure relates to compounds of Formula I and process of obtaining the same.
Said compounds of Formula I is employed in the syntheses of pyrroloquinoline quinone (PQQ),
4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid 2-allyl ester, 5-
ethoxy-5-hydroxy-4-oxo-4,5-dihydro-1H-...
The present disclosure relates generally to the field of Biotechnology and Protein Science, and specifically to Enzyme preparation. The present disclosure provides a process for preparation of recombinant and stable proteases including but not limited to Trypsin, Carboxypeptidase B and Kexin. The production of these...
“PROCESS FOR ENHANCED EXPRESSION OF INSULIN AND ITS ANALOGS AND METHODS THEREOF”
ABSTRACT
The present disclosure describes a method for production of recombinant peptides and proteins. In particular, the present disclosure relates to a method for the production of insulin and insulin analogs. The expression cons...
The present invention relates to primers and methods for analyzing chimerism in conditions such as Bone Marrow Transplantation (BMT) using a broad spectrum of Variable Number of Tandem Repeats (VNTRs) or Short Tandem Repeats (STRs) or a combination thereof by qPCR (Quantitative Real Time Polymerase Chain Reaction). ...
The present invention relates to a novel method for high throughput detection of wide range of genotoxins in eukaryotic cells wherein the eukaryotic cell based tool combines the ability to detect a broad spectrum of genotoxic signaling events and a simple and reproducible assay technique. The present invention furth...
The present invention relates to a recombinant DNA expression/secretion system in E. coliwherein the said system combines the potential of signal peptide-based translocation of recombinant proteins to the periplasmic space of E. coli with membrane defective mutants of E. coli to further aid secretion into the extrac...
Title: Synthesis of Tocotrienols from o-Cresol Derivatives
The present invention provides an environmentally benign, facile process forpreparation of Tocotrienols from commercially available derivatives of o-Cresol.
“A PROCESS FOR BIOGAS PRODUCTION AND APPLICATION THEREOF”
ABSTRACT
The present disclosure relates to a process for producing biogas by inoculating the waste cell with the dung of domestic animal and subjecting the inoculated wasted cell mass to anaerobic digestion. Said process produces enhanced biogas yield w...
Title:SYNTHESIS OF A GUANYLATE CYCLASE AGONIST BY FRAGMENTS BASED APPROACH.
The present invention provides a process for the synthesis of Plecanatide, a guanylate cyclase agonist. The process involves convergent synthesis with compounds, i.e.,fragment of peptides followed by cyclization. The method provides high ...
This invention relates to the field of synthetic organic chemistry. The invention provides an improved and economical method of preparation of Guanylate Cyclase 2c Agonist with high yield. The method of preparation has simple reaction operation, easy post-processing and economical value. The process can be easily sc...
The present invention relates to a process for preparation of compounds of Formula I and its isomers. Particularly, the present invention provides a process for the preparation of a type of Vitamin K2, Menaquinone 7 (MK-7). More particularly the disclosure involves process of preparing Menaquinone 7 (MK-7) and its i...
The present invention provides a continuous flow process for preparing sulphobutyl ether cyclodextrin derivative having an average degree of substitution of 5.8-6.9. The process can be scale up to >50 kg/day to meet the industrial requirements. The process comprises the steps of activation of cyclodextrin in presenc...
The present invention provides a method of preparation of GLP-1 peptides by using different peptide fragments having amino acid sequences SEQ ID NO:1 (Fragment IG), SEQ ID NO:2 (Fragment SG), Fragment BG, SEQ ID NO:3, and SEQ ID NO:4 and combinations thereof. The method of preparation is environmentally benign, simp...
The present invention relates to a method for the preparation of ß-D-galactosamine and its salts and a-D-galactosamine and its salts. The synthesis method reduces process steps, does not involve hazardous reactant conditions or use of expensive starting reagents, significantly reduces process cycle time, which in tu...
The present invention relates to a method for the preparation of cholesterol (Compound of Formula I). More specifically, the present invention relates to synthesizing intermediates involved in the synthesis of Compound of Formula I in a process efficient method. The present method does not involve expensive reagents...
The present invention relates to a process of preparation of glucagon-like peptide-1 (GLP-1) analogues using novel fragments approach with tagging approach. More particularly, the disclosure provides synthesis method of glucagon like peptides via fragment approach with tagging approach and sequential amino acids cou...
The present invention relates to the field of synthetic organic chemistry and provides a method for the preparation of glycolipid carboxylic acids and their salts. Specifically, the present invention involves the synthesis of compounds of Formula I and their salts through intermediates of Formula 1-d and Formula II....
Registered Trademarks
[Class : 5] Pharmaceutical, Dietetic Substances Adapted For Medical Use
[Class : 5] Pharmaceutical, Dietetic Substances Adapted For Medical Use.
[Class : 5] Pharmaceutical, Dietetic Substances Adapted For Medical Use.
View +4 more Brands for Anthem Biosciences Private Limited.
Charges
24 May 2019
Syndicate Bank
22 Crore
16 May 2017
Hdfc Bank Limited
75 Crore
14 February 2017
Biotechnology Industry Research Assistance Council
11 Crore
21 October 2016
Syndicate Bank
17 Crore
29 July 2015
Citi Bank N.a.
12 Crore
27 May 2015
Export-import Bank Of India
45 Crore
27 March 2015
Syndicate Bank
75 Crore
26 May 2014
Citi Bank N.a.
29 Crore
10 August 2015
Syndicate Bank
29 Crore
10 August 2015
Syndicate Bank
9 Crore
11 March 2007
State Bank Of India
38 Crore
22 December 2019
Citi Bank N.a.
32 Crore
16 February 2023
Others
0
15 September 2022
Citi Bank N.a.
0
22 December 2019
Citi Bank N.a.
0
16 May 2017
Hdfc Bank Limited
0
14 February 2017
Others
0
26 May 2014
Citi Bank N.a.
0
21 October 2016
Syndicate Bank
0
11 March 2007
State Bank Of India
0
10 August 2015
Syndicate Bank
0
27 March 2015
Syndicate Bank
0
27 May 2015
Export-import Bank Of India
0
10 August 2015
Syndicate Bank
0
29 July 2015
Citi Bank N.a.
0
24 May 2019
Syndicate Bank
0
16 February 2023
Others
0
15 September 2022
Citi Bank N.a.
0
22 December 2019
Citi Bank N.a.
0
16 May 2017
Hdfc Bank Limited
0
14 February 2017
Others
0
26 May 2014
Citi Bank N.a.
0
21 October 2016
Syndicate Bank
0
11 March 2007
State Bank Of India
0
10 August 2015
Syndicate Bank
0
27 March 2015
Syndicate Bank
0
27 May 2015
Export-import Bank Of India
0
10 August 2015
Syndicate Bank
0
29 July 2015
Citi Bank N.a.
0
24 May 2019
Syndicate Bank
0
16 February 2023
Others
0
15 September 2022
Citi Bank N.a.
0
22 December 2019
Citi Bank N.a.
0
16 May 2017
Hdfc Bank Limited
0
14 February 2017
Others
0
26 May 2014
Citi Bank N.a.
0
21 October 2016
Syndicate Bank
0
11 March 2007
State Bank Of India
0
10 August 2015
Syndicate Bank
0
27 March 2015
Syndicate Bank
0
27 May 2015
Export-import Bank Of India
0
10 August 2015
Syndicate Bank
0
29 July 2015
Citi Bank N.a.
0
24 May 2019
Syndicate Bank
0
Documents
Form MSME FORM I-22092020_signed
Instrument(s) of creation or modification of charge;-19022020
Particulars of all joint charge holders;-19022020
Optional Attachment-(1)-19022020
Form CHG-1-19022020_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200219
Form CHG-1-10022020_signed
Particulars of all joint charge holders;-10022020
Optional Attachment-(1)-10022020
Instrument(s) of creation or modification of charge;-10022020
CERTIFICATE OF REGISTRATION OF CHARGE-20200210
Form AOC-4(XBRL)-29012020-signed
Copy of MGT-8-23012020
List of share holders, debenture holders;-23012020
Form MGT-7-23012020_signed
Form ADT-1-22012020_signed
Copy of written consent given by auditor-22012020
Copy of resolution passed by the company-22012020
Copy of the intimation sent by company-22012020
Form CHG-4-14012020_signed
Letter of the charge holder stating that the amount has been satisfied-14012020
CERTIFICATE OF SATISFACTION OF CHARGE-20200114
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-06012020
Form ADT-1-10102019_signed
Copy of resolution passed by the company-10102019
Optional Attachment-(1)-10102019
Copy of written consent given by auditor-10102019
Copy of the intimation sent by company-10102019
Form MGT-14-20092019_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-20092019
